
Sign up to save your podcasts
Or


Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.
By Dr. Neil Love4.4
6363 ratings
Prof Peter Schmid from Barts Cancer Institute in London reviews available efficacy and safety data guiding the optimal management of metastatic triple-negative breast cancer.
CME information and select publications here.

134 Listeners

321 Listeners

504 Listeners

30 Listeners

75 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

44 Listeners

59 Listeners

3,374 Listeners

1,150 Listeners

46 Listeners

367 Listeners

59 Listeners

0 Listeners